Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA's risk communication plan coming soon

This article was originally published in The Tan Sheet

Executive Summary

FDA could release its strategic plan to ensure it accurately communicates to consumers the risks and benefits of medical products in as early as one month, according to Janet Woodcock, director of the Center for Drug Evaluation and Research. The plan will include a list of 14 actions FDA will take in the next year to improve its risk communication strategies. It will also list around 60 actions FDA hopes to take in the next few years, Woodcock said Sept. 21 at the Food and Drug Law Institute conference in Washington

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS103388

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel